REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Rv Farmaceutica Limitada (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Rv Farmaceutica Limitada Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Rv Farmaceutica Limitada is a company in Colombia, with a head office in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 22, 2012. There are currently 5 (2024) people employed by Rv Farmaceutica Limitada. There was a net sales revenue increase of 68.21% reported in Rv Farmaceutica Limitada’s latest financial highlights for 2024. Its’ total assets recorded a growth of 30.79%. Rv Farmaceutica Limitada’s net profit margin decreased by 1.97% in 2024.

Headquarters
Carrera 31 A 2 A 77
Bogota D.C.; Bogota D.C; Postal Code: 0601

Contact Details: Purchase the Rv Farmaceutica Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Rv Farmaceutica Limitada report to view the information.
Financial Auditors:
Purchase the Rv Farmaceutica Limitada report to view the information.
Incorporation Date:
February 22, 2012
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Rv Farmaceutica Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
68.21%▲
Total operating revenue
68.21%▲
Operating profit (EBIT)
66.63%▲
Net Profit (Loss) for the Period
31.28%▲
Total Assets
30.79%▲
Total Equity
41.38%▲
Operating Profit Margin (ROS)
-0.18%▼
Net Profit Margin
-1.97%▼
Return on Equity (ROE)
-1.5%▼
Quick Ratio
0.31%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo